FDA.reportPublic FDA data

osilodrostat 10 MG Oral Tablet [Isturisa]

RxCUI
2286285
RxNorm name
osilodrostat 10 MG Oral Tablet [Isturisa]
Display name
osilodrostat 10 MG Oral Tablet [Isturisa]
Full name
osilodrostat 10 MG Oral Tablet [Isturisa]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
IsturisaOSILODROSTATRecordati Rare Diseases, Inc.f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae22025-11-18Warnings, Adverse reactionsExact identifier
rxcui: 2286285

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2Isturisa 10 MG Oral Tablet [PSN] · osilodrostat 10 MG Oral Tablet [Isturisa] [SBD] · Isturisa 10 MG (as osilodrostat phosphate 14.3 MG) Oral Tablet [SY] · Isturisa 10 MG Oral Tablet [SY]410These highlights do not include all the information needed to use ISTURISA ® safely and effectively. See full prescribing information for ISTURISA. ISTURISA (osilodrostat) tablets, for oral use Initial U.S. Approval: 202020251118